Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (DRKS00037985) titled 'Conjunctival and chorioretinal vascular alterations in Osler's disease' on Sept. 25.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: diagnostic
Primary Sponsor: Klinik fur Augenheilkunde, Universitatsklinikum des Saarlandes UKS
Condition:
I78.0
Hereditary haemorrhagic telangiectasia
Intervention:
Group 1: Non-interventional observational study:
All enrolled adult patients with Osler's disease (hereditary hemorrhagic telangiectasia, HHT) will undergo systematic evaluation without any therapeutic intervention. Observation period 2025-2027: single assessment...